CAS: 40951-39-1; 4-Aminopiperidine-4-Carboxylic Acid

该化合物是一种多用途的七环化合物,其特点是在管状动物脚架上有氨基和箱状酸性功能组,这种结构使其成为制药和有机合成的宝贵中间体,特别是用于开发生物活性分子和消毒器.它的硬性管状核和双功能再活性能够进行精确的修改,为有定制特性的化合物设计提供便利.该化合物的稳定性和与标准混合试剂的兼容性增强了其在peptide化学和药用化学应用中的效用.它通常被用于合成酶抑制剂,受体叶管和其他药用活性剂,提供了反应性和结构多样性的平衡.

结构式图片

相似化合物

183673-66-7 183673-71-4 288154-16-5

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10087221-B2
    优先权日:2013-03-21
    标题 :Synthesis of hydantoin containing peptide products
    发明人:HENKEL BERND
    权利人:SANOFI AVENTIS DEUTSCHLAND
    摘要:The present invention relates to a method of synthesizing a peptide product comprising at least one hydantoin group. The peptide product may be used as a reference material for the quality control of pharmaceutical peptides, particularly for the quality control of exendin peptides. Further, the invention relates to hydantoin building blocks, a method for manufacturing such building blocks and their use for the synthesis of peptide products.

    专利号:US-5880295-A
    优先权日:1994-02-16
    标 题 :Process for the preparation of diamine intermediates useful in the synthesis of HIV protease inhibitors
    发明人:KALTENBACH III ROBERT FRANK
    权利人:DU PONT PHARM CO
    摘要:The present invention provides a process for the preparation of compounds of formula (V) below, and analogs thereof, which are useful as intermediates for the synthesis of HIV protease inhibitors, including cyclic ureas. ##STR1##

    专利号:US-6022977-A
    优先权日:1997-03-26
    标 题 :Dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids
    发明人:ZHANG LIN-HUA; ANZALONE LUIGI; PESTI JAAN A; YIN JIANGUO
    权利人:DU PONT PHARM CO
    摘要:The present invention relates generally to a novel method for preparation of substituted isoxazolin-5-yl acetic acid in high optical purity from a stereoisomeric mixture of an esterified substituted isoxazolin-5-yl acetate. The products are useful in the synthesis of compounds for pharmaceuticals, especially the treatment of thrombolytic disorders, and agricultural products.

    专利号:US-5530124-A
    优先权日:1994-06-30
    标 题:Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
    发明人:RADESCA LILIAN A; HARRIS GREGORY D; WAT EDWARD K W; WALTERMIRE ROBERT E
    权利人:DU PONT MERCK PHARMA
    摘要:This invention provides improved synthetic processes for the preparation of hydroxy-protected cyclic urea compounds of Formula (IX), ##STR1## which are useful as intermediates for the preparation of cyclic urea human immunodeficiency virus (HIV) protease inhibitors, from N-protected aminoaldehydes. The processes of the present invention provide high yields, can be conducted on multikilogram scale, and eliminate the need for chromatographic purification of intermediates or final product.

    专利号:WO-2024146948-A1
    优先权日:2023-01-05
    标题:Peptide synthesis method involving sterically hindered tri-tert-butyl-tryptophan (tbt) residue
    发明人:EKSTEEN JACOBUS JOHANNES; SVENDSEN JOHN SIGURD; MALMEDY FLORENCE; GUEVARA JONATHAN
    权利人:AMICOAT AS
    摘要:The invention is directed to a method of peptide synthesis comprising reacting a compound of Formula (I) or a salt thereof with a carbodiimide reagent to form an O-acylisourea intermediate; reacting the O-acylisourea intermediate with an additive to form an activated ester; and reacting the activated ester with an amino-containing moiety which is an amino acid, a peptide or a salt thereof comprising an amino group, wherein the amino group forms an amide bond with the carbonyl marked * in Formula (I); wherein the compound of Formula (I) has the structure: and wherein R1 and R2 are as defined in the disclosure. The invention is also directed to a compound of Formula (III) as defined in the disclosure or a salt thereof.

    专利号:WO-0043352-A1
    优先权日:1999-01-22
    标题:A method for the synthesis of compounds of formula 1 and derivatives thereof
    南京华安药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nanjingpharma.com
    电话: 025-58394007👤
    📞南京华安药业有限公司 ⚠️参考联系方式

    销售电话:025-58394007
    邮箱:sales@nanjingpharma.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1111/j.1399-3011.2005.00312.x
    摘要:Haynes SR, Hagins SD, Juban MM, Elzer PH, Hammer RP. Improved solid-phase synthesis of alpha,alpha-dialkylated amino acid-rich peptides with antimicrobial activity. J Pept Res. 2005 Dec;66(6):333–47. doi: 10.1111/j.1399-3011.2005.00312.x.
    参考文献:10.1021/jm901788j
    摘要:McHardy T, Caldwell JJ, Cheung K, Hunter LJ, Taylor K, Rowlands M, Ruddle R, Henley A, de Haven Brandon A, Valenti M, Davies TG, Fazal L, Seavers L, Raynaud FI, Eccles SA, Aherne GW, Garrett MD, Collins I. Discovery of 4-Amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides As Selective, Orally Active Inhibitors of Protein Kinase B (Akt). J. Med. Chem. 2010 Feb 12;53(5):2239–49. doi: 10.1021/jm901788j.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知